🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

A Dimensional Model for Personality Disorders in Later Life

RecruitingNAAges 18 Years - anyAllUniversitair Ziekenhuis Brussel
NCT05548946 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Research on personality disorders (PDs) in older adults is currently limited. This is surprising, given that PDs are also common in this age group. Moreover, PDs show high co-morbidity with other disorders (both mental and physical) and often have a negative effect on treatment. With this in mind, the conceptualization, diagnosis and treatment of PDs in older adults represents an important task for mental health care. To this end, problems with the current classification of PDs need to be tackled, as they currently complicate this task. The current DSM-5 (Diagnostic and Statistical Manual, Edition 5) (APA, 2013) categorical PD criteria are mainly based on the living conditions of younger adults and are therefore often not suited for PD diagnosis in older adults. Currently, however, a paradigm shift is taking place from a categorical to a dimensional approach of PDs. The "Alternative Mode

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Clinical population (inpatients and outpatients) Inclusion Criteria: * ONLY older adults: from the age of 65 * Dutch speaking Exclusion Criteria (as evaluated by the psychiatrists and psychologists of the participating institutions): * Severe cognitive impairment (Patients who are admitted because of cognitive impairment will be excluded from the participant pool, other than this the psychiatrists and psychologists of the participating institutions will make an evaluation of the patients' cognitive capacities) * Acute state of mental impairment which would interfere with the reliability of the patients' responses (for example severe psychosis), as evaluated by the psychiatrists and psychologist of the participating institutions.
💊

What it tests

  • PID-5-BF+M and LPFS-BF 2.0 (self-report questionnaires)
  • Secondary Questionnaires (self-report and informant questionnaires)
  • Clinical Ratings of the dimensional model
  • PID-5-BF+M and LPFS-BF 2.0 (Informant questionnaires)
📍

Where

2 sites
Alexianen Zorggroep Tienen
Tienen, Belgium
Mondriaan
Heerlen, Netherlands
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy